News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
659,893 Results
Type
Article (50702)
Company Profile (332)
Press Release (608859)
Section
Business (190304)
Career Advice (2304)
Deals (33750)
Drug Delivery (113)
Drug Development (80185)
Employer Resources (137)
FDA (16458)
Job Trends (15014)
News (329636)
Policy (32852)
Tag
Academia (2626)
Alliances (47448)
Alzheimer's disease (1226)
Approvals (16377)
Artificial intelligence (149)
Bankruptcy (301)
Best Places to Work (11524)
Biotechnology (213)
Breast cancer (129)
Cancer (1123)
Cardiovascular disease (106)
Career advice (1916)
Cell therapy (253)
Clinical research (63842)
Collaboration (393)
Compensation (188)
COVID-19 (2481)
C-suite (105)
Data (1113)
Diabetes (164)
Diagnostics (5746)
Drug pricing (101)
Earnings (72196)
Employer resources (123)
Events (102537)
Executive appointments (327)
FDA (17006)
Funding (346)
Gene therapy (185)
GLP-1 (666)
Government (4554)
Healthcare (19023)
Infectious disease (2567)
Inflammatory bowel disease (118)
Interviews (405)
IPO (15128)
Job creations (3891)
Job search strategy (1651)
Layoffs (420)
Legal (7508)
Lung cancer (187)
Manufacturing (184)
Medical device (13812)
Medtech (13817)
Mergers & acquisitions (18719)
Metabolic disorders (463)
Neuroscience (1520)
NextGen Class of 2024 (6551)
Non-profit (4421)
Northern California (1452)
Obesity (266)
Opinion (236)
Patents (99)
People (56971)
Pharmaceutical (96)
Phase I (20414)
Phase II (27782)
Phase III (20900)
Pipeline (453)
Postmarket research (2573)
Preclinical (8073)
Radiopharmaceuticals (254)
Rare diseases (228)
Real estate (5741)
Regulatory (22133)
Research institute (2379)
Resumes & cover letters (353)
Southern California (1236)
Startups (3613)
United States (13270)
Vaccines (571)
Weight loss (218)
Date
Today (132)
Last 7 days (785)
Last 30 days (3768)
Last 365 days (35803)
2024 (32789)
2023 (40062)
2022 (50662)
2021 (54591)
2020 (52933)
2019 (46364)
2018 (35173)
2017 (32504)
2016 (31678)
2015 (36522)
2014 (29168)
2013 (24825)
2012 (26637)
2011 (26881)
2010 (25796)
Location
Africa (839)
Arizona (149)
Asia (41085)
Australia (6662)
California (3221)
Canada (1210)
China (250)
Colorado (152)
Connecticut (157)
Europe (88835)
Florida (444)
Georgia (117)
Illinois (368)
Indiana (209)
Maryland (596)
Massachusetts (2617)
Michigan (130)
Minnesota (266)
New Jersey (948)
New York (910)
North Carolina (779)
Northern California (1452)
Ohio (128)
Pennsylvania (816)
South America (1179)
Southern California (1236)
Texas (446)
Washington State (355)
659,893 Results for "i med pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Business
Lilly, Pfizer Take Meds Straight To Consumers in Renewed DTC Push
Big Pharma has finally gotten its arms around something advocates have wanted for a long time: direct-to-consumer sales. Eli Lilly and Pfizer are leading the way.
September 4, 2024
·
5 min read
·
Annalee Armstrong
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Press Releases
Delta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-14927
November 5, 2024
·
1 min read
Press Releases
SpyGlass Pharma Completes Enrollment in Phase I/II Study of its Promising Long-Term Drug Delivery Platform for Glaucoma and Ocular Hypertension
November 20, 2024
·
2 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Opinion
Opinion: A Small Pharma Mindset Can Reshape Big Pharma and Improve Patient Care
An appreciation for practicality, independent thinking and patient care can help disrupt the bureaucracy of Big Pharma.
September 12, 2024
·
3 min read
·
Jill Marie Drury
Press Releases
SAI MedPartners Expands Strategic Service Offering Through Acquisition of IDEA Pharma
November 14, 2024
·
2 min read
Deals
Sanofi Dips Into Red-Hot Radiopharma Space With $110M Licensing Deal
Sanofi will join Big Pharma peers Novartis, BMS and Eli Lilly in radioligands, striking a $110 million licensing deal with RadioMedix and Orano Med to develop AlphaMedix for neuroendocrine tumors.
September 12, 2024
·
1 min read
·
Annalee Armstrong
1 of 65,990
Next
